Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Trying for an Over-Counter Cholesterol Drug

Article Abstract:

Pharmaceutical companies Merck and Company Inc. and Johnson & Johnson have come together in an effort to have Mevacor, one of the oldest cholesterol-lowering products, sold as an over-the-counter drug. An advisory panel at the Food and Drug Administration will hear their case today.

Author: Saul, Stephanie
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
United States, Joint ventures, Marketing procedures, Government regulation, Pharmaceutical Preparation Manufacturing, Patents & copyrights, Lipotropics & Cholesterol Reducers, Marketing, Complications and side effects, Intellectual property, Licensing, certification and accreditation, Company marketing practices, Johnson & Johnson, Company joint venture, Anticholesteremic agents, JNJ, Nonprescription drugs, Merck & Company Inc., Statins, Mevacor (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


City Cashes In as Mecca for the Hefty (With Wallets to Match)

Article Abstract:

Durham, North Carolina has become the diet capital of the United States. Diet clinics like the Rice Diet House, Structure House and the Duke Diet and Fitness Center bring approximately $51 million into the Durham economy each year.

Author: Saul, Stephanie
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Facilities & equipment, Commodity & service prices, North Carolina, Weight Control Centers, Diet and Weight Reducing Centers, Miscellaneous personal services, not elsewhere classified, Economic aspects, Prices and rates, Buildings and facilities, Reducing clinics, Weight loss industry, Diet industry, Company pricing policy, Durham, North Carolina

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Fraud Case Filed Against Ex-Officers Of Bristol

Article Abstract:

Securities fraud charges were filed against two ex-Bristol-Myers Squibb executives, but the company avoided indictment by agreeing to pay $300 million.

Author: Saul, Stephanie
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Legal issues & crime, Financial management, New Jersey, Executive changes & profiles, Securities issued, listed, Officials and employees, Company legal issue, Finance, Investigations, Securities, Securities fraud, Bristol-Myers Squibb Co., BMY, Company securities, Company financing, Schiff, Frederick S., Lane, Richard J.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry
Similar abstracts:
  • Abstracts: The rising force on the right: Jesse Helms flexes his conservative muscle. John Major's surprise
  • Abstracts: Cheap - and deadly: heroin usage is up because of a price drop
  • Abstracts: High anxieties: Canada's no. 2 airline raises the stakes in a costly struggle against Air Canada
  • Abstracts: Hey, get your ice-hot beer here! Only in Canada: the CRTC's stupidity. When Canada shuts down
  • Abstracts: A deadly outbreak: the mysterious Ebola virus strikes again. Family ties: tracing the genetic link to a deadly cancer
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.